BioPharma

PSDs are not an 'obligation' under trade agreement April 9, 2021

The claim the publication of PBAC PSDs is an obligation under the US-Australia FTA is as wrong as suggesting the industry was extensively consulted over the removal of submission sponsor confidentiality.

More risk for government this time around in agreement negotiation April 9, 2021

Dr Brendan Shaw says the negotiation of new industry agreements is hampered by a lack of ambition or willingness to consider system-level change.

This change will not enhance transparency of decision-making April 9, 2021

In no way does this Bill increase the transparency of PBS decision-making processes. All it does is increase the government's right to make company information transparent.

Daily updates on COVID-19 vaccine - 9 April 2021 April 9, 2021

The number of COVID-19 vaccines administered globally has topped 704 million across 153 countries, according to Bloomberg. The latest daily rate of doses administered is 16.1 million.

Government scraps October timeline after accepting ATAGI advice April 9, 2021

In effect, ATAGI is saying the rare risk of blood clots associated with the vaccine exceeds the very low risk of serious COVID-19 infection in people aged under 50.

More come forward to question move on confidentiality protections April 9, 2021

Merck and the Generic and Biosimilar Medicines Association are the latest to question the federal government's move to scrap confidentiality protections for sponsors of PBAC submissions.

Guild's Trent Twomey on costs and the access challenge April 8, 2021

In the second in a two-part series, the Pharmacy Guild's Trent Twomey discusses the need for reform of opiate dependence therapy, out-of-pocket costs and expresses concern over the challenge companies face in navigating the PBS-listing process.

Government giving itself the power to unilaterally disclose confidential prices April 8, 2021

The change will give the government the lawful power to unilaterally release any information provided by a sponsor, including prices that will no longer be protected.

Daily updates on COVID-19 vaccine - 8 April 2021 April 8, 2021

The global COVAX facility has now shipped 37 million vaccine doses to 90 countries with the latest recipients East Timor (24,000) and Iran (700,800).

Industry and advocacy groups say change threatens access April 8, 2021

The industry and advocacy groups are lining up to challenge the federal government's attempt to legislate away confidentiality provisions for PBAC submission sponsors.

GMHBA announces a new member of board of directors April 7, 2021

GMHBA chair, Claire Higgins, said, “Sandy’s knowledge of the community and health care sectors, together with his expertise at a CEO and Executive level will be invaluable to GMHBA."

nib marks one year of providing COVID-19 support April 7, 2021

nib has announced it has marked one year since the launch of its COVID-19 support package that was designed to assist members and the wider community who have been impacted by the pandemic.

Latest Video

Most Read

More risk for government this time around in agreement negotiation

Government scraps October timeline after accepting ATAGI advice

More come forward to question move on confidentiality protections

PSDs are not an 'obligation' under trade agreement

This change will not enhance transparency of decision-making

New Stories

PSDs are not an 'obligation' under trade agreement

More risk for government this time around in agreement negotiation

This change will not enhance transparency of decision-making

Daily updates on COVID-19 vaccine - 9 April 2021

Government scraps October timeline after accepting ATAGI advice

More come forward to question move on confidentiality protections

Guild's Trent Twomey on costs and the access challenge

Sign In

Latest Video

Most Read

More risk for government this time around in agreement negotiation

Government scraps October timeline after accepting ATAGI advice

More come forward to question move on confidentiality protections

PSDs are not an 'obligation' under trade agreement

This change will not enhance transparency of decision-making

Follow Us

New Stories

PSDs are not an 'obligation' under trade agreement

More risk for government this time around in agreement negotiation

This change will not enhance transparency of decision-making

Daily updates on COVID-19 vaccine - 9 April 2021

Government scraps October timeline after accepting ATAGI advice

More come forward to question move on confidentiality protections

Guild's Trent Twomey on costs and the access challenge